343
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

A qualitative study of the views about smoking, licensed cessation aids and e-cigarettes in people with schizophrenia spectrum disorders

&

References

  • Dickerson F, Stallings CR, Origoni AE, Vaughan C, Khushalani S, Schroeder J, Yolken RH. Cigarette smoking among persons with schizophrenia or bipolar disorder in routine clinical settings, 1999–2011. PS. 2013;64(1):44–50. doi:10.1176/appi.ps.201200143.
  • Smith PH, Mazure CM, McKee SA. Smoking and mental illness in the US population. Tob Control. 2014;23(e2):e147–e153. doi:10.1136/tobaccocontrol-2013-051466.
  • Davis SC. 2014. Annual Report of the Chief Medical Officer 2013: Public Mental Health Priorities-Investing in the Evidence. Department of Health.
  • Royal College of Physicians, Royal College of Psychiatrists. Smoking and mental health. London: RCP, 2013.
  • Jochelson J, Majrowski B. Clearing the air. Debating smoke-free policies in psychiatric units. King’s Fund. 2006.
  • Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM. Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls. Drug Alcohol Depend. 2005;80(2):259–65. doi:10.1016/j.drugalcdep.2005.04.002.
  • Williams JM, Gandhi KK, Lu S-E, Kumar S, Shen J, Foulds J, Kipen H, Benowitz NL. Higher nicotine levels in schizophrenia compared with controls after smoking a single cigarette. Nicotine Tob Res. 2010a;12(8):855–9. doi:10.1093/ntr/ntq102.
  • Williams JM, Gandhi KK, Lu SE, Kumar S, Steinberg ML, Cottler B, Benowitz NL. Shorter interpuff interval is associated with higher nicotine intake in smokers with schizophrenia. Drug Alcohol Depend. 2011;118(2-3):313–9. doi:10.1016/j.drugalcdep.2011.04.009.
  • Kelly DL, McMahon RP, Wehring HJ, Liu F, Mackowick KM, Boggs DL, Warren KR, Feldman S, Shim J-C, Love RC, et al. Cigarette smoking and mortality risk in people with schizophrenia. Schizophrenia Bull. 2011;37(4):832–8. doi:10.1093/schbul/sbp152.
  • Callaghan RC, Veldhuizen S, Jeysingh T, Orlan C, Graham C, Kakouris G, Remington G, Gatley J. Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression. J Psychiatr Res. 2014;48(1):102–10. doi:10.1016/j.jpsychires.2013.09.014.
  • Heiberg IH, Jacobsen BK, Nesvåg R, Bramness JG, Reichborn-Kjennerud T, Naess Ø, Ystrom E, Hultman CM, Høye A. Total and cause-specific standardized mortality ratios in patients with schizophrenia and/or substance use disorder. PLoS One. 2018;13(8):e0202028. doi:10.1371/journal.pone.0202028.
  • Campion J, Shiers D, Britton J, Gilbody S, Bradshaw T. 2014. Primary Care Guidance on Smoking and Mental Disorders – 2014 update. Royal College of General Practitioners & Royal College of Psychiatrists.
  • Fiore MC. US public health service clinical practice guideline: treating tobacco use and dependence. Respir Care. 2000;45(10):1200–62.
  • Royal College of Physicians (RCP). Hiding in plain sight: treating tobacco dependency in the NHS. London: RCP, 2018.
  • Cather C, Pachas GN, Cieslak KM, Evins AE. Achieving smoking cessation in individuals with schizophrenia: special considerations. CNS Drugs. 2017;31(6):471–81. doi:10.1007/s40263-017-0438-8.
  • Roberts E, Eden Evins A, McNeill A, Robson D. Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta‐analysis. Addiction. 2016;111(4):599–612. doi:10.1111/add.13236.
  • West R, Evins AE, Benowitz NL, Russ C, McRae T, Lawrence D, St Aubin L, Krishen A, Maravic MC, Anthenelli RM, et al. Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES. Addiction. 2018;113(8):1507–16. doi:10.1111/add.14208.
  • Beard E, West R, Michie S, Brown J. Association of prevalence of electronic cigarette use with smoking cessation and cigarette consumption in England: a time-series analysis between 2006 and 2017. Addiction. 2020;115(5):961–74. doi:10.1111/add.14851.
  • Jackson SE, Kotz D, West R, Brown J. Moderators of real-world effectiveness of smoking cessation aids: a population study. Addiction. 2019;114(9):1627–38. doi:10.1111/add.14656.
  • Hajek P, Phillips-Waller A, Przulj D, Pesola F, Myers Smith K, Bisal N, Li J, Parrott S, Sasieni P, Dawkins L, et al. A randomized trial of E-cigarettes versus nicotine-replacement therapy. N Engl J Med. 2019;380(7):629–37. doi:10.1056/NEJMoa1808779.
  • Caponnetto P, Auditore R, Russo C, Cappello GC, Polosa R. Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. Int J Environ Res Public Health. 2013d;10(2):446–61. doi:10.3390/ijerph10020446.
  • Pratt SI, Sargent J, Daniels L, Santos MM, Brunette M. Appeal of electronic cigarettes in smokers with serious mental illness. Addict Behav. 2016;59:30–4. doi:10.1016/j.addbeh.2016.03.009.
  • Hickling LM, Perez-Iglesias R, McNeill A, Dawkins L, Moxham J, Ruffell T, et al. A pre-post pilot study of electronic cigarettes to reduce smoking in people with severe mental illness. Psychol Med. 2018:1–8.
  • McNeill A, Brose L, Calder R, Bauld L, Robson D. 2020. Vaping in England: an evidence update including mental healthvand pregnancy, March 2020vA report commissioned by Public Health England, England.
  • Lum A, Skelton E, Wynne O, Bonevski B. A systematic review of psychosocial barriers and facilitators to smoking cessation in people living with schizophrenia. Front Psychiatry. 2018;9:565. doi:10.3389/fpsyt.2018.00565.
  • Smith CA, McNeill A, Kock L, Ahmed Z, Shahab L. Mental health professionals' perceptions, judgements and decision-making practices regarding the use of electronic cigarettes as a tobacco harm reduction intervention in mental healthcare: a qualitative focus group study. Addict Behav Rep. 2019;10:100184. doi:10.1016/j.abrep.2019.100184.
  • Etter M, Mohr S, Garin C, Etter JF. Stages of change in smokers with schizophrenia or schizoaffective disorder and in the general population. Schizophrenia Bull. 2004;30(2):459–68. doi:10.1093/oxfordjournals.schbul.a007092.
  • Kerr S, Woods C, Knussen C, Watson H, Hunter R. Breaking the habit: a qualitative exploration of barriers and facilitators to smoking cessation in people with enduring mental health problems. BMC Public Health. 2013;13:221. doi:10.1186/1471-2458-13-221.
  • de Leon J, Diaz FJ, Aguilar MC, Jurado D, Gurpegui M. Does smoking reduce akathisia? Testing a narrow version of the self-medication hypothesis. Schizophr Res. 2006;86(1–3):256–68. doi:10.1016/j.schres.2006.05.009.
  • Esterberg ML, Compton MT. Smoking behavior in persons with a schizophrenia-spectrum disorder: a qualitative investigation of the transtheoretical model. Soc Sci Med. 2005;61(2):293–303. doi:10.1016/j.socscimed.2004.11.057
  • Ratschen E, Britton J, Doody G, Mcneill A.. Smoking Attitudes, Behaviour and Nicotine Dependence Among Mental Health Acute Inpatients: an Exploratory Study. International Journal of Social Psychiatry. 2010;56(2): 107–118. doi:10.1177/0020764008101855
  • Knowles S, Planner C, Bradshaw T, Peckham E, Man M-S, Gilbody S. Making the journey with me: a qualitative study of experiences of a bespoke mental health smoking cessation intervention for service users with serious mental illness. BMC Psychiatry. 2016;16:193.
  • Sharma R, Wigginton B, Meurk C, Ford P, Gartner CE. Motivations and limitations associated with lapin among people with mental illness: a qualitative analysis of Reddit discussions. IJERPH. 2016;14(1):1–15. doi:10.3390/ijerph14010007.
  • Sharma R, Meurk C, Ford P, Beere D, Gartner C. Are Australian smokers with mental illness receiving adequate smoking cessation and harm reduction information? Int J Ment Health Nurs. 2018;27(6):1673–88. doi:10.1111/inm.12465.
  • Meurk C, Ford P, Sharma R, Fitzgerald L, Gartner C. Views and preferences for nicotine products as an alternative to smoking: A focus group study of people living with mental disorders. IJERPH. 2016;13(11):1166. doi:10.3390/ijerph13111166.
  • Flick U. An introduction to qualitative research. (1st-3rd ed). London: Sage, 2006.
  • Gorman GE. 2005. Qualitative research for the information professional: a practical handbook. (2nd ed.). London: Facet.
  • Moustakas C. 1994. Phenomenological research methods. Thousand Oaks, CA: Sage.
  • Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101. doi:10.1191/1478088706qp063oa.
  • Mendrek A, Bourque J, Dubé A, Lakis N, Champagne J. Emotion processing in women with schizophrenia is menstrual cycle phase and affective valence dependent: an FMRI study. ISRN Psychiatry. 2012;2012:656274. doi:10.5402/2012/656274.
  • Kotz D, Brown J, West R. Predictive validity of the Motivation To Stop Scale (MTSS): a single-item measure of motivation to stop smoking. Drug Alcohol Depend. 2013;128(1-2):15–9. doi:10.1016/j.drugalcdep.2012.07.012.
  • Creswell JW. 1998. Qualitative inquiry and research design: Choosing among five traditions. Thousand Oaks, CA: Sage Publications, Inc.
  • Pearson JL, Hitchman SC, Brose LS, Bauld L, Glasser AM, Villanti AC, McNeill A, Abrams DB, Cohen JE. Recommended core items to assess e-cigarette use in population-based surveys. Tob Control. 2018;27(3):341–6. doi:10.1136/tobaccocontrol-2016-053541.
  • Bandura A, Walters RH. 1963. Social learning and personality development. New York: Holt Rinehart and Winston.
  • Poulsen LH, Osler M, Roberts C, Due P, Damsgaard MT, Holstein BE. Exposure to teachers smoking and adolescent smoking behaviour: analysis of cross-sectional data from Denmark. Tob Control. 2002;11(3):246–51. doi:10.1136/tc.11.3.246.
  • OSSFAD. Osservatorio Droga Alcol e Fumo. Rapporto Annuale Sul Fumo. XVIII Convegno Tabagismo e Servizio Sanitario Nazionale. 2016.
  • de Leon J, Diaz FJ, Rogers T, Browne D, Dinsmore L. Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders. Schizophr Res. 2002;56(1-2):47–54. doi:10.1016/S0920-9964(01)00217-1.
  • Carpenter CM, Wayne GF, Connolly GN. The role of sensory perception in the development and targeting of tobacco products. Addiction. 2007;102(1):136–47. doi:10.1111/j.1360-0443.2006.01649.x.
  • Rees VW, Kreslake JM, Wayne GF, O'Connor RJ, Cummings KM, Connolly GN. Role of cigarette sensory cues in modifying puffing topography. Drug Alcohol Depend. 2012;124(1-2):1–10. doi:10.1016/j.drugalcdep.2012.01.012.
  • Dawkins L, Munafo M, Christoforou G, Olumegbon N, Soar K. The effects of e-cigarette visual appearance on craving and withdrawal symptoms in abstinent smokers. Psychol Addict Behav. 2016;30(1):101–5. doi:10.1037/adb0000112.
  • Goldenson NI, Kirkpatrick MG, Barrington-Trimis JL, Pang RD, McBeth JF, Pentz MA, Samet JM, Leventhal AM. Effects of sweet flavorings and nicotine on the appeal and sensory properties of e-cigarettes among young adult vapers: application of a novel methodology. Drug Alcohol Depend. 2016;168:176–80. doi:10.1016/j.drugalcdep.2016.09.014.
  • Royal College of Physicians, Royal College of Psychiatrists. The prescribing of varenicline and vaping (electronic cigarettes) to patients with severe mental illness. London: RCP, 2016.
  • Miller BJ, Wang A, Wong J, Paletta N, Buckley PF. E-cigarette use in schizophrenia: prevalence and attitudes. Ann Clin Psychiatry. 2017;29(1):4–10.
  • White AR, Rampes H, Liu JP, Stead LF, Campbell J. Acupuncture and related interventions for smoking cessation. Cochrane Database Syst Rev. 2014.
  • Filia SL, Baker AL, Gurvich CT, Richmond R, Lewin TJ, Kulkarni J. Gender differences in characteristics and outcomes of smokers diagnosed with psychosis participating in a smoking cessation intervention. Psychiatry Res. 2014;215(3):586–93. doi:10.1016/j.psychres.2014.01.002.
  • Kowalczyk WJ, Wehring HJ, Burton G, Raley H, Feldman S, Heishman SJ, Kelly DL. Predictors of the perception of smoking health risks in smokers with or without schizophrenia. J Dual Diag. 2017;13(1):29–35. doi:10.1080/15504263.2016.1260190.
  • York LN. 1997. A phenomenological investigation of cigarette smoking in persons with severe and persistent mental illness Doctoral dissertation, Saint Louis University, St Louis.
  • Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, Ascher J, Russ C, Krishen A, Evins AE, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016;387(10037):2507–20. doi:10.1016/S0140-6736(16)30272-0.
  • Cahill K, Stevens S, Lancaster T. Pharmacological treatments for smoking cessation. JAMA. 2014;311(2):193–4. doi:10.1001/jama.2013.283787.
  • Goldberg JO. Successful change in tobacco use in schizophrenia. J Am Psychiatr Nurses Assoc. 2010;16(1):30–5. doi:10.1177/1078390309357084.
  • Briskman I, Bar G, Boaz M, Shargorodsky M. Impact of co-morbid mental illness on the diagnosis and management of patients hospitalized for medical conditions in a general hospital. Int J Psychiatry Med. 2012;43(4):339–48. doi:10.2190/PM.43.4.d.
  • Trainor K, Leavey G. Barriers and facilitators to smoking cessation among people with severe mental illness: a critical appraisal of qualitative studies. NICTOB. 2017;19(1):14–23. doi:10.1093/ntr/ntw183.
  • Chen L-S, Baker T, Brownson RC, Carney RM, Jorenby D, Hartz S, Smock N, Johnson M, Ziedonis D, Bierut LJ, et al. Smoking cessation and electronic cigarettes in community mentalhealth centers: patient and provider perspectives. Community Ment Health J. 2017;53(6):695–702. doi:10.1007/s10597-016-0065-8.
  • Rass O, Pacek LR, Johnson PS, Johnson MW. Characterizing use patterns and perceptions of relative harm in dual users of electronic and tobacco cigarettes. Exp Clin Psychopharmacol. 2015;23(6):494–503. doi:10.1037/pha0000050.
  • Pepper JK, Emery SL, Ribisl KM, Rini CM, Brewer NT. How risky is it to use e-cigarettes? Smokers' beliefs about their health risks from using novel and traditional tobacco products. J Behav Med. 2015;38(2):318–26. doi:10.1007/s10865-014-9605-2.
  • Baltz & Lach. Perceptions, knowledge, and use of electronic cigarettes: a survey of mental health patients. Issues Mental Health Nurs. 2019;40(10):887–894.
  • Majeed BA, Weaver SR, Gregory KR, Whitney CF, Slovic P, Pechacek TF, Eriksen MP. Changing perceptions of harm of e-cigarettes among US adults, 2012–2015. Am J Prev Med. 2017;52(3):331–8. doi:10.1016/j.amepre.2016.08.039.
  • Timothy HR, Walker DM, Mullen D, Johnson TJ, Ford EW. Trends in E-Cigarette Awareness and Perceived Harmfulness in the U.S. Am J Prev Med. 2017;52(3):339–46. doi:10.1016/j.amepre.2016.10.017.
  • Smith CA, Shahab L, McNeill A, Jackson SE, Brown J, Brose L. Harm perceptions of e-cigarettes among smokers with and without mental health conditions in England: a cross-sectional population survey. Nicotine Tobacco Res. 2020:1–8. doi:10.1093/ntr/ntaa020.
  • Spears CA, Jones DM, Weaver SR, Yang B, Pechacek TF, Eriksen MP. Use of and perceptions about electronic nicotine delivery systems (ENDS) among people with mental health conditions or serious psychological distress, 2018. Drug Alcohol Depend. 2020;212:108049. doi:10.1016/j.drugalcdep.2020.108049.
  • Pawlikowska, T., Zhang, W., Griffiths, F., van Dalen, J., & van der Vleuten, C. Verbal and non-verbal behavior of doctors and patients in primary care consultations–How this relates to patient enablement. Patient education and counseling, 2012;86(1), 70–76.
  • Osuna E, Pérez-Carrión A, Pérez-Cárceles MD, Machado F. Perceptions of health professionals about the quality of communication and deliberation with the patient and its impact on the health decision making process. J Public Health Res. 2018;7(3):116–121. doi:10.4081/jphr.2018.1445.
  • Warner KE, Burns DM. Hardening and the hard-core smoker: concepts, evidence, and implications. Nicotine Tob Res. 2003;5(1):37–48. doi:10.1080/1462220021000060428.
  • Lawn SJ, Pols RG, Barber JG. Smoking and quitting: a qualitative study with community-living psychiatric clients. Soc Sci Med. 2002;54(1):93–104. doi:10.1016/S0277-9536(01)00008-9.
  • Siru R, Hulse GK, Tait RJ. Assessing motivation to quit smoking in people with mental illness: a review. Addiction. 2009;104(5):719–33. doi:10.1111/j.1360-0443.2009.02545.x.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.